Rohto Pharmaceutical Co., Ltd. (4527) Press Release
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 (Three Months Ended June 30, 2026)
Earlier from Rohto Pharmaceutical
- Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
- Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities